All (n = 100) | Continuous CO2 (n = 50) | One-shot CO2 (n = 50) | P-value | |
---|---|---|---|---|
Age (years) | 66 (62–76) | 65 (62–78) | 69 (67–79) | < 0.001 |
Male sex | 52.5% | 43.9% | 38.7% | < 0.001 |
Body mass index (kg/m2) | 25.8 (22.2–28.8) | 26.8 (23.4–29.0) | 24.3 (21.7–28.4) | 0.191 |
Arterial hypertension | 32.2% | 33.3% | 36.1% | 0.789 |
Diabetes mellitus | ||||
Oral antidiabetic drugs | 8.9% | 7.2% | 5.5% | 0.006 |
Insulin | 2.3% | 2.8% | 2.6% | 0.530 |
Hypercholesterolemia | 77.4% | 38.1% | 39.3% | 0.899 |
Renal dysfunction* | 1.4% | 2.3% | 2.1% | 0.254 |
Respiratory or lung disease | 2.1% | 2.3% | 1.9% | 0.187 |
Previous disabling stroke | 1.5% | 1.5% | 1.3% | 0.687 |
History of cancer | 1.4% | 1.9% | 2.5% | 0.030 |
Atrial fibrillation | 9.4% | 8.3% | 11.2% | < 0.001 |
Peripheral vascular disease | 1.8% | 1.6% | 1.9% | 0.556 |
Coronary artery disease | 0.9% | 0.8% | 1.1% | 0.81 |
LVEF | 0.347 | |||
>50% | 93.0% | 92.0% | 91.2% | |
30–50% | 6.3% | 7.5% | 7.5% | |
<30% | 0.7% | 0.5% | 1.3% | |
Previous surgery | 2.3% | 1.7% | 1.9% | 0.211 |
EuroSCORE II (%) | 1.2 (1.1–2.8) | 1.2 (1.1–2.7) | 1.2 (1.1–2.8) | 0.87 |